Apersys

Apersys keeps donated organs alive outside the body for up to 7 days, a major leap from today’s 24-hour limit. Physicians gain time to test, treat and heal organs that would otherwise be discarded, turning emergency transplants into planned procedures. Granted FDA Breakthrough Device Designation and born at ETH Zurich, the platform goes beyond transplant by opening new frontiers in drug testing and gene therapy on living human tissue.